Case Study: Expanding AstraZeneca Mölndal Compound Management Capacity & Services to Support the New R&D Strategy

This FREE webinar was recorded on:
Tuesday, February 21, 2012
12:00 PM - 01:00 PM EST
To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.
Become a member to Watch

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

  • Consolidating more work on the Mölndal site without overworking the Compound Management group
  • Re-deploying automated systems and investing in supplementary tools
  • First integration between an RTS high speed cherry picking and reformatting store and a BioCel


Maximiliano Zaragoza-Sundqvist
Associate Teamleader

Max started working in the Compound Management group at AstraZeneca R&D Mölndal in 2000 and has since then been involved in numerous acquisitions and implementations of automated systems. After a two year long excursion into the land of physical quality of compounds he returned to compound management in the summer of 2007. Max currently holds a position as Associate Teamleader which involves responsibility for the compound management process in Mölndal along with its automation.